Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:55 PM ET 10-Q
Financial Results Edgemode, Inc. EDGM

Edgemode Q3 2026 Results: Net Loss of $1.37M

Edgemode, Inc. reported a net loss of $10.5 million for the nine months ended September 30, 2026, compared to a loss of $14.4 million in the prior year period. The company's balance sheet shows a significant stockholders' deficit of $7.6 million and a substantial reduction in derivative liabilities from $15.4 million to $1.5 million during the year.

Key figure
Net loss $1.37M
4:55 PM ET 10-Q
Financial Results American Strategic Investment Co. NYC

American Strategic Investment Q3 2026 Results: Net Loss of $6.72M

American Strategic Investment Co. reported a net loss of $22.8 million for the nine months ended September 30, 2026, compared to a $14.5 million loss in the prior year. The company's total equity decreased to $47.3 million from $64.8 million at year-end 2025, primarily driven by the net loss and offset by common stock issuances to its Advisor.

Key figure
Net loss $6.72M
4:53 PM ET 10-Q
Financial Results Hines Global Income Trust, Inc. HGIT

Hines Global Income Trust Q3 2026 Results: Net Loss of $21.3M, Loss Widens

This document is a formal consent from Altus Group U.S., Inc. allowing Hines Global Income Trust, Inc. to reference their role as an independent valuer in the company's Q3 2026 Quarterly Report. It specifically pertains to the valuation process described in the Net Asset Value section of the filing.

Key figure
Net loss $21.3M
4:52 PM ET 10-Q
Financial Results Origin Investment Corp I ORIQ

Origin Investment Corp I Q3 2026 Results: Net Income $391K, Up 1.9% YoY

Origin Investment Corp I reported a net income of $1,165,890 for the nine months ended September 30, 2026, primarily driven by $1,937,643 in interest income from its Trust Account. As a blank check company, it has not yet commenced operations or generated revenue, and its total assets of $73.36 million are largely comprised of investments held in trust for a future business combination.

Key figure
Net income $391K · +1.9% YoY
4:52 PM ET 8-K
Financial Results Cerenome, Inc. CNSY

Cerenome Financial Results

Cerenome (formerly Plus Therapeutics) reported Q3 2026 financial results, highlighting its first quarter of CNSide diagnostic revenue totaling $0.7 million. The company expanded its payer coverage to approximately 190 million lives and completed enrollment in its Phase 2 glioblastoma trial. Additionally, the company rebranded from Plus Therapeutics to Cerenome during the quarter.

Term
Q3 2026

“Recognition of our first quarter of CNSide® diagnostic revenue and commercial payments beginning in October is a tremendous landmark. Furthermore, our payer universe continues to expand with now about 80% of U.S. private payers representing approximately 190 million covered lives. Most recently, with Aetna coverage, it gives physicians an in-network option for both tumor cell enumeration and molecular profiling. In parallel, our growing commercial team is focused on helping more cancer centers use our test in patient care. In therapeutics, we materially advanced our two key programs by completing enrollment in our Phase 2 trial in adults with recurrent glioblastoma, opening up higher dose cohorts in the repeat dosing of REYOBIQ™ in patients with leptomeningeal metastases and reporting interim data in that trial.”

Marc H. Hedrick, M.D., Cerenome’s President and Chief Executive Officer
4:52 PM ET 10-Q
Financial Results Ckx Lands, Inc. CKX

Ckx Lands Q3 2026 Results: Net Income $444K, Up 167.0% YoY

CKX Lands, Inc. reported net income of $621,499 for the nine months ended September 30, 2026, an increase from $442,919 in the prior year period, driven largely by higher surface revenue and interest income. Total assets remained stable at approximately $22.4 million, while the company maintained a strong liquidity position with $15.9 million in cash and cash equivalents.

Key figure
Net income $444K · +167.0% YoY
4:52 PM ET 8-K
Financial Results Seritage Growth Properties SRG

Seritage Growth Properties Financial Results

Seritage Growth Properties reported Q3 2026 financial results, achieving net income of $2.7 million compared to a net loss for the nine-month period. The company generated $3.0 million from asset sales and received an $8.9 million distribution from an unconsolidated entity, while continuing to evaluate strategic options for its remaining portfolio.

Term
Q3 2026

“Although we have no new transactions under contract, we continue to work on both individual asset sales and potential strategic options for the portfolio and the Company”

Adam Metz, CEO & President
4:50 PM ET 10-Q
Financial Results Grown Rogue International Inc. GRUSF

Grown Rogue International Q3 2026 Results: Net Loss of $8.89M

Grown Rogue International Inc. reported total revenue of $31.45 million for the nine months ended September 30, 2026, compared to $23.67 million in the prior year period. The company experienced a net loss of $12.58 million for the nine-month period, primarily driven by a $5.03 million loss on the acquisition of Rogue EBC and significant increases in general and administrative expenses.

Key figure
Net loss $8.89M
4:49 PM ET 8-K
Financial Results American Strategic Investment Co. NYC

American Strategic Investment Financial Results

American Strategic Investment Co. reported third quarter 2026 revenue of $7.1 million and a net loss of $6.7 million. The results reflect a decrease in revenue compared to the prior year due to the disposition of the 1140 Avenue of the Americas property. Subsequent to the quarter, the company signed a major lease extension and expansion with the State of New York at its 123 William Street property.

“The Company’s results this quarter build on the progress we made over the last two quarters, as our capital prioritization strategy continues to contribute to our results. The portfolio’s high quality, largely investment grade tenant base continues to support stable performance this year.”

Nicholas Schorsch, Jr., CEO of ASIC

“We remain focused on completing our remaining asset dispositions and directing capital toward the opportunities we believe will create the most durable value for our shareholders, such as the execution of the lease with the State of New York after the end of the quarter that increases pro-forma occupancy at 123 William Street to approximately 75% and portfolio occupancy to approximately 78%.”

Nicholas Schorsch, Jr., CEO of ASIC
4:48 PM ET 8-K
Financial Results Femasys Inc FEMY

Femasys Financial Results

Femasys reported financial results for the third quarter of 2026, highlighting a slight increase in U.S. sales to $0.35 million despite overall sales declining due to international distributor order timing. The company completed a $30 million private placement in August to fund the build-out of its U.S. commercial team and support the FemBloc pivotal trial.

Term
Q3 2026

“We maintained a lean team and tightly managed resources as we prioritized financing from long-term institutional investors. Closing the $30 million in financing in mid-August 2026 represents an important turning point for Femasys.”

Kathy Lee-Sepsick, Founder and Chief Executive Officer

“These results and commercial recruitment progress give us strong confidence that deploying our team in target U.S. territories will broaden adoption and drive revenue growth.”

Kathy Lee-Sepsick, Founder and Chief Executive Officer
4:48 PM ET 10-Q
Financial Results AB Private Credit Investors Corp

AB Private Credit Investors Q3 2026 Results: Net Income $18.8M, Up 9.2% YoY

For the nine months ended September 30, 2026, AB Private Credit Investors Corp reported net investment income after tax of $47.9 million, a significant increase from $42.3 million in the prior year period. However, net assets resulting from operations decreased to $24.2 million from $41.7 million year-over-year, primarily due to $22.3 million in net unrealized depreciation on investments.

Key figure
Net income $18.8M · +9.2% YoY
4:48 PM ET 8-K
Financial Results NextPlat Corp NXPL

NextPlat Financial Results

NextPlat Corp reported third quarter 2026 financial results featuring a 35% improvement in gross profit and a 66% reduction in net loss. While consolidated revenue decreased to $10.5 million due to lower reimbursement rates, the company saw 300% growth in high-margin pharmacy contract revenue, specifically driven by 340B services.

Term
Q3 2026

“Our third quarter results reflect continued year-over-year improvement across the business, driven by the refocusing of our healthcare operations on high-value, high-margin services designed to deliver consistent bottom-line results in what remains a dynamic market.”

David Phipps, Chief Executive Officer and President of NextPlat Corp

“Our focus remains on growth and profitability through our differentiated, high-value healthcare services and expanding community pharmacy network, including our new Scott’s location near Pensacola and a new pharmacy in Jacksonville, supported by a more efficient operating structure.”

David Phipps, Chief Executive Officer and President of NextPlat Corp
4:47 PM ET 10-Q
Financial Results Crescent Private Credit Income Corp

Crescent Private Credit Income Q3 2026 Results: Net Income $14.3M, Up 115.9% YoY

Crescent Private Credit Income Corp reported total investment income of $62.2 million for the nine months ended September 30, 2026, a significant increase from $30.8 million in the prior year period. Net investment income rose to $33.2 million, though the company recorded net realized and unrealized losses on investments during the period.

Key figure
Net income $14.3M · +115.9% YoY
4:47 PM ET 10-Q
Financial Results Seritage Growth Properties SRG

Seritage Growth Properties Q3 2026 Results: Turns Profitable, Net Income $3.96M

Seritage Growth Properties continued its strategic plan to liquidate its real estate portfolio, focusing on asset dispositions to retire outstanding debt. The filing reflects a decrease in rental income as properties are sold, consistent with the company's transition toward dissolution.

Key figure
Net income $3.96M
4:47 PM ET 10-Q
Financial Results Farmers & Merchants Bancshares, Inc. FMFG

Farmers & Merchants Bancshares Q3 2026 Results: Net Income $2.02M, Up 18.7% YoY

Farmers & Merchants Bancshares, Inc. reported net income of $5.75 million for the nine months ended September 30, 2026, an increase from $4.07 million in the prior year period. The company saw a significant rise in net interest income to $20.7 million, driven by higher loan yields and a decrease in interest expense on deposits.

Key figure
Net income $2.02M · +18.7% YoY
4:47 PM ET 10-Q
Financial Results Biofrontera Inc. BFRI

Biofrontera Q3 2026 Results: Net Loss of $6.42M, Loss Narrows

Biofrontera Inc. reported a net loss of $11.8 million for the nine months ended September 30, 2026, an improvement from the $16.2 million loss in the prior year period. Product revenues grew significantly to $31.2 million compared to $24.6 million in 2025, while the company's cash position decreased to $3.2 million as of the reporting date.

Key figure
Net loss $6.42M
4:45 PM ET 10-Q
Financial Results KKR Infrastructure Conglomerate LLC

KKR Infrastructure Conglomerate Q3 2026 Results: Net Income $300M, Up 144.8% YoY

For the nine months ended September 30, 2026, KKR Infrastructure Conglomerate LLC reported a net increase in net assets resulting from operations of $558.0 million, driven by $589.2 million in unrealized appreciation on investments. Total assets grew to $9.22 billion from $6.59 billion at year-end 2025, reflecting significant capital deployment and investment performance.

Key figure
Net income $300M · +144.8% YoY
4:45 PM ET 10-Q
Financial Results Palomino Laboratories Inc. PALX

Palomino Laboratories Q3 2026 Results: Net Loss of $4.42M, Loss Widens

Palomino Laboratories Inc. reported a net loss of $7.03 million for the nine months ended September 30, 2026, compared to a $2.42 million loss in the prior year, driven by a significant increase in R&D and G&A expenses. The company strengthened its balance sheet during the period, ending the quarter with $17.79 million in cash and cash equivalents.

Key figure
Net loss $4.42M
4:44 PM ET 10-Q
Financial Results AtlasClear Holdings, Inc. ATCH

AtlasClear Holdings Q1 2026 Results: Net Loss of $1.05M, Loss Widens

AtlasClear Holdings reported a net loss of $1.05 million for the quarter ended September 30, 2026, compared to a loss of $0.44 million in the prior year period. While total revenues increased to $5.39 million driven by new stock locate fees, the company faced a delisting notice from NYSE American due to its low stock price and has transitioned trading to the OTC Pink Limited Market.

Key figure
Net loss $1.05M
4:40 PM ET 10-Q
Financial Results Lftd Partners Inc. LIFD

Lftd Partners Q3 2026 Results: Net Loss of $3.34M

LFTD Partners Inc. reported a significant decrease in total assets from $19.27 million at year-end 2025 to $8.32 million as of September 30, 2026, primarily driven by a sharp reduction in inventory and accounts receivable. The company's total liabilities also decreased to $4.64 million, while management noted substantial doubt about the company's ability to continue as a going concern.

Key figure
Net loss $3.34M
4:40 PM ET 10-Q
Financial Results zSpace, Inc. ZSPC

zSpace Q3 2026 Results: Net Loss of $1.24M, Loss Narrows

zSpace, Inc. reported a significant decrease in revenue to $14.2 million for the nine months ended September 30, 2026, compared to $23.0 million in the prior year. Despite the revenue decline, the net loss narrowed to $7.5 million from $18.1 million, aided by a $4.1 million gain on debt extinguishment and a $2.2 million gain from the change in fair value of preferred stock liabilities.

Key figure
Net loss $1.24M
4:38 PM ET 10-Q
Financial Results WTI Fund XI, Inc.

WTI Fund XI Q3 2026 Results: Turns Profitable, Net Income $134K

WTI Fund XI, Inc. reported a significant increase in total investment income to $13.7 million for the nine months ended September 30, 2026, compared to $6.7 million in the prior year period. Net assets grew to $37.9 million, driven by $20.6 million in shareholder contributions and a net increase in net assets from operations of $3.7 million, despite a $1.2 million unrealized loss on loans.

Key figure
Net income $134K
4:37 PM ET 10-Q
Financial Results XMax Inc. XMAX

XMax Q3 2026 Results: Net Loss of $8.98M, Loss Widens

XMax Inc. reported a significant net income of $23.6 million for the nine months ended September 30, 2026, primarily driven by a $32.4 million unrealized gain on investments. This represents a substantial turnaround from a net loss of $1.8 million in the prior year period, despite a decrease in total revenue from $15.0 million to $10.9 million.

Key figure
Net loss $8.98M
4:36 PM ET 10-Q
Financial Results Eva Live Inc GOAI

Eva Live Q3 2026 Results: Net Loss of $54.9M

Eva Live Inc. reported a significant net loss of $65.2 million for the nine months ended September 30, 2026, primarily driven by a massive increase in general and administrative expenses including $58.3 million in stock-based compensation. Despite a slight decrease in total revenue to $11.8 million, the company significantly expanded its equity base through various share issuances for services and debt settlements.

Key figure
Net loss $54.9M
4:36 PM ET 10-Q
Financial Results Northwest Biotherapeutics Inc NWBO

Northwest Biotherapeutics Q3 2026 Results: Net Loss of $28.8M, Loss Widens

Northwest Biotherapeutics reported a net loss of $41.1 million for the nine months ended September 30, 2026, an improvement from the $61.6 million loss in the prior year period. Total revenues increased to $2.2 million from $0.7 million, while operating expenses decreased significantly from $47.1 million to $34.6 million.

Key figure
Net loss $28.8M
4:36 PM ET 8-K
Financial Results Air T Inc AIRT

Air T Financial Results

Air T, Inc. reported financial results for its second fiscal quarter ended September 30, 2026, with revenue increasing 129% to $146.9 million, primarily driven by the acquisition of Regional Express Holdings (Rex). The company reported a net loss of $7.48 per share, impacted by operational challenges at Rex including unscheduled engine removals and high fuel costs.

Term
Q2 2027

“While focused in one sector and with some interdependencies, Air T can be viewed as a set of businesses that operate independently of one another. The quarter just passed is an example of widely variable operational dynamics across our businesses.”

Nick Swenson, Company Chairman and CEO

“Rex financial performance was notably challenged in the quarter due to a combination of unscheduled engine removals, delays at engine overhaul shops and a doubling of fuel costs compared to pre-war levels.”

Nick Swenson, Company Chairman and CEO
4:35 PM ET 8-K
Financial Results Calidi Biotherapeutics, Inc. CLDI

Calidi Biotherapeutics Financial Results

Calidi Biotherapeutics reported a net loss of $3.6 million for the third quarter of 2026, a significant improvement from the $10.8 million loss in the prior year period. The company highlighted preclinical progress for its CLD-401 program and implemented a restructuring plan on November 6, 2026, to reduce headcount and save $3 million annually. During the quarter, the company also raised $1.2 million through an at-the-market offering to extend its cash runway.

Term
Q3 2026

“Throughout the third quarter, Calidi continued to advance its RedTail platform for systemic and local delivery and redefine the potential of oncolytic viruses and genetic medicine. In particular, CLD-401 demonstrated remarkable anti-tumor activity with systemic administration in syngeneic tumor models and continues to progress towards the clinic.”

Eric Poma, Ph.D., Calidi Biotherapeutics CEO
4:35 PM ET 10-Q
Financial Results WTI Fund X, Inc.

WTI Fund X Q3 2026 Results: Net Loss of $5.18M

WTI Fund X, Inc. reported a net increase in net assets resulting from operations of $26.2 million for the nine months ended September 30, 2026, down slightly from $27.6 million in the prior year period. The company significantly reduced its debt facility borrowings from $232.5 million at year-end 2025 to $95.0 million, while net assets increased to $209.2 million.

Key figure
Net loss $5.18M
4:35 PM ET 10-Q
Financial Results Adm Endeavors, Inc. ADMQ

Adm Endeavors Q3 2026 Results: Net Income $197K, Down 8.7% YoY

ADM Endeavors, Inc. reported total revenue of $4.58 million for the nine months ended September 30, 2026, a slight increase from $4.31 million in the prior year period. The company achieved a net income of $127,075 for the first nine months of 2026, down from $250,321 in 2025, primarily due to significantly higher interest expenses and the absence of a large gain on an insurance claim seen in the previous year.

Key figure
Net income $197K · -8.7% YoY
4:34 PM ET 10-Q
Financial Results Forbright, Inc. FRBT

Forbright Q3 2026 Results: Net Income $20.6M, Down 35.7% YoY

Forbright, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 33,601,078 shares of Class A common stock outstanding. The filing highlights a pending branch sale agreement and the adoption of the 2026 Omnibus Incentive Plan, while emphasizing risks related to AI implementation and credit quality.

Key figure
Net income $20.6M · -35.7% YoY

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.